Pramipexole

Drug Levels and Effects:




Summary of Use during Lactation:


No information is available on the use of pramipexole during breastfeeding, but it suppresses serum prolactin and may interfere with breastfeeding. An alternate drug may be preferred, especially while nursing a newborn or preterm infant.


Drug Levels:


Maternal Levels.

Relevant published information was not found as of the revision date.

Infant Levels.

Relevant published information was not found as of the revision date.


Effects in Breastfed Infants:


Relevant published information was not found as of the revision date.


Possible Effects on Lactation:


Relevant published information in nursing mothers was not found as of the revision date.Pramipexolelowers serum prolactin.[1] The prolactin level in a mother with established lactation may not affect her ability to breastfeed.


References:


1. Schilling JC, Adamus WS, Palluk R . Neuroendocrine and side effect profile of pramipexole , a new dopamine receptor agonist, in humans. Clin Pharmacol Ther. 1992;51:541-8. PMID:1350237



Substance Identification:




Substance Name:

Pramipexole

CAS Registry Number:

104632-26-0

Drug Class:


  • Antiparkinson Agents

  • Dopamine Agonists


  • Administrative Information:




    LactMed Record Number:


    639


    Last Revision Date:


    Disclaimer:Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.